Temporal correlation of impaired immune response after thermal injury with susceptibility to infection in a murine model.
Suppression of cellular immunity and increased susceptibility to sepsis frequently accompany thermal injury. However, a convincing association between the two has been difficult to establish in human beings. Therefore we chose to investigate the relationship of impaired cell-mediated immunity with susceptibility to sepsis in an animal model. We studied the response to phytohemagglutinin (PHA) and interleukin-2 (IL-2) production by splenocytes from mice subjected to a standard 25% scald burn and killed at intervals of 3, 5, 7, 10, 14, and 25 days after thermal injury. Burned mice were compared in all instances to sham-burn animals (i.e., animals that had been anesthetized and shaved but not burned). We also studied mortality after cecal ligation and puncture (CLP), as a septic challenge, in burned and control animals at the same postburn intervals. We found maximal suppression (50% to 55%) of the PHA response at 10 to 14 days after injury and maximum suppression (68%) of IL-2 production at 7 days. Both of these parameters returned to normal by postinjury day 28. Mortality after CLP increased gradually from control levels after thermal injury up to a maximum of 88% on postburn day 10 and also returned to control levels after 28 days after burn. Significant correlations were found between mortality after CLP in the postburn period and suppression of the PHA response, on the one hand, and the suppression of IL-2 production, on the other (r = 0.89 and 0.91, respectively; p less than 0.05). This result implies a causal relationship between impaired cell-mediated immunity and susceptibility to sepsis after burn injury.
Moss
N M
NM
Department of Surgery, Harvard Medical School, Boston, MA 02115.
Gough
D B
DB
Jordan
A L
AL
Grbic
J T
JT
Wood
J J
JJ
Rodrick
M L
ML
Mannick
J A
JA
D000818:Animals; D001424:Bacterial Infections / Q000209:etiology / Q000276:immunology*; D002056:Burns / Q000276:immunology* / Q000401:mortality / Q000601:surgery; D002432:Cecum / Q000601:surgery; D007113:Immunity, Innate; D007165:Immunosuppression Therapy; D007376:Interleukin-2 / Q000096:biosynthesis; D008026:Ligation / Q000009:adverse effects; D008297:Male; D051379:Mice; D008805:Mice, Inbred A; D010835:Phytohemagglutinins; D011183:Postoperative Complications / Q000209:etiology; D011677:Punctures / Q000009:adverse effects
D007376:Interleukin-2; D010835:Phytohemagglutinins